Chemical Structure For Zonisamide 100mg Capsule (Zonisamide Caps 100mg 8266 Invagen For Cipla 1)
Zonisamide Capsule
Product Images NDC 0615-8266
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 0615-8266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Zonisamide Caps 100mg 8266 Invagen For Cipla 2)
This appears to be a graph showing the reduction in all partial seizure rates in patients who were given zonisamide and those who were given a placebo. The graph also shows the proportion of patients achieving different levels of seizure reduction. The y-axis is labeled as "% of patients" and the x-axis appears to be labeled as "Improvement" and "Worsening".*
Principal Display Panel Zonisamide Caps Usp 100 mg (Zonisamide Caps 100mg 8266 Invagen For Cipla 3)
This is a label of the medicine Tonisamide Caps USP 100 mg manufactured by Invagen for Cipla. The lot number is 8266 with an unknown expiration date. There are several other lot numbers mentioned on the package along with the manufacturer's name and drug information. The package should be stored between 20°C to 25°C (68°F to 77°F) and should be protected from light and moisture. The rest of the text mostly contains repeated information about the drug, lot numbers, and instructions for storage & institutional use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
